Stock ALOPM ONCODESIGN PRECISION MEDICINE
Add to a list
To use this feature you must be a member
Log inSign up

Company Oncodesign Precision Medicine

Equities

ALOPM

FR001400CM63

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 13:35:13 23/05/2024 BST 		5-day change 1st Jan Change
1.245 EUR +0.40% Intraday chart for Oncodesign Precision Medicine -4.23% -31.22%
05-15 Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents CI
01-25 Oncodesign Precision Medicine: fundraising on the horizon CF

Business Summary

Oncodesign Precision Medicine specializes in the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology. The company aims to discover new targeted therapy molecules for cancers without current solutions, including therapy-resistant and metastatic cancers.

Number of employees: 19

Sales per Business

EUR in Million2022Weight2023Weight Delta
Precision Medicine
100.0 %
8 100.0 % 1 100.0 % -86.57%

Sales per region

EUR in Million2022Weight2023Weight Delta
France
100.0 %
8 100.0 % 1 100.0 % -86.57%

Managers

Managers TitleAgeSince
Philippe Genne CEO
 Chief Executive Officer 62 30/08/22
Jan Hoflack BRD
 Director/Board Member 63 13/09/22
Karine Lignel BRD
 Director/Board Member 55 13/09/22

Members of the board

Members of the board TitleAgeSince
Kamel Besseghir BRD
 Director/Board Member 75 13/09/22
Philippe Genne CEO
 Chief Executive Officer 62 30/08/22
Karine Lignel BRD
 Director/Board Member 55 13/09/22
Jan Hoflack BRD
 Director/Board Member 63 13/09/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,679,514 14,741,813 ( 88.38 %) 44,588 ( 0.2673 %) 88.38 %

Shareholders

NameEquities%Valuation
OFI Invest Asset Management SA
0.8688 %
158,037 0.8688 % 248 403 €
Claresco Finance SA
0.3727 %
67,795 0.3727 % 106 560 €
Gestys SA
0.0770 %
14,000 0.0770 % 22 005 €

Company contact information

Oncodesign Precision Medicine SA

18 rue Jean Mazen

21000, Dijon

+33 310 451 820

address Oncodesign Precision Medicine(ALOPM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Ratings for Oncodesign Precision Medicine

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.245 EUR
Average target price
2.48 EUR
Spread / Average Target
+99.20%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ONCODESIGN PRECISION MEDICINE Stock Oncodesign Precision Medicine
-31.22% 22.45M
MODERNA, INC. Stock Moderna, Inc.
+64.92% 62.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.85% 41.38B
LONZA GROUP AG Stock Lonza Group AG
+44.76% 40.38B
CELLTRION, INC. Stock Celltrion, Inc.
-8.93% 27.64B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.05% 26.46B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.96% 18.9B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.21% 12.67B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.74% 12.27B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.42% 12.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALOPM Stock
  4. Company Oncodesign Precision Medicine